Developmental and epileptic encephalopathy, 11
MONDO:0013388Any early infantile epileptic encephalopathy in which the cause of the disease is a mutation in the SCN2A gene.
Also known as: DEE11, EIEE11, SCN2A early infantile epileptic encephalopathy, developmental and epileptic encephalopathy 11, early infantile epileptic encephalopathy caused by mutation in SCN2A, epileptic encephalopathy, early infantile, 11, epileptic encephalopathy, early infantile, type 11
21 clinical trials for this condition and its sub-types, 4 tagged with Developmental and epileptic encephalopathy, 11 itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Can a new drug tame severe childhood epilepsy?
Disease control OngoingThis trial is testing an experimental drug called PRAX-222 in children aged 2 to 18 who have a rare, severe form of epilepsy caused by changes in the SCN2A gene. The goal is to see if the drug is safe and can reduce how often seizures happen. Participants will receive either PRAX…
Phase 1/2 • Sponsor: Praxis Precision Medicines • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New hope for kids with hard-to-treat genetic seizures
Disease control OngoingThis study tests a new medicine called PRAX-562 in 77 children with rare genetic epilepsies (SCN2A or SCN8A). The goal is to see if it safely reduces motor seizures. The trial has two parts: a double-blind phase where some children get the drug and some get a placebo, followed by…
Phase 2/3 • Sponsor: Praxis Precision Medicines • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC